Cargando…
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past 30 years. In order to reduce disease prevalence, extensive research has been ongoing to impr...
Autores principales: | Jung, Chan-Young, Yoo, Tae-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987689/ https://www.ncbi.nlm.nih.gov/pubmed/35385633 http://dx.doi.org/10.4093/dmj.2021.0329 |
Ejemplares similares
-
Novel biomarkers for diabetic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2022) -
MicroRNAs in peripheral artery disease: potential biomarkers and
pathophysiological mechanisms
por: Ring, Andrew, et al.
Publicado: (2022) -
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015) -
A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease
por: Krishna, Smriti Murali, et al.
Publicado: (2015) -
Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease
por: Khanijou, Vuthi, et al.
Publicado: (2022)